Literature DB >> 3069202

Toxic shock syndrome.

J K Todd1.   

Abstract

In the past 10 years, we have learned much about TSS and S. aureus and its toxins. A number of important biologic principles have been reemphasized in this first decade of TSS research: S. aureus is a very complex organism, one not likely to yield quick answers; in vitro observations must always be confirmed in the patient; animal models may not always be reliable replicates of human disease; and epidemiologic associations cannot be equated with causation. Toxic shock is an intricate phenomenon with many interesting scientific facets. Unraveling its mysteries will undoubtedly teach us more about the complex interaction of patients and microorganisms.

Entities:  

Mesh:

Year:  1988        PMID: 3069202      PMCID: PMC358064          DOI: 10.1128/CMR.1.4.432

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  186 in total

1.  Corticosteroid therapy for patients with toxic shock syndrome.

Authors:  J K Todd; M Ressman; S A Caston; B H Todd; A M Wiesenthal
Journal:  JAMA       Date:  1984-12-28       Impact factor: 56.272

2.  Genetic characterization and cloning of the toxic shock syndrome exotoxin.

Authors:  B N Kreiswirth; M O'Reilly; R P Novick
Journal:  Surv Synth Pathol Res       Date:  1984

3.  Biological properties of toxic shock syndrome exotoxin.

Authors:  P M Schlievert
Journal:  Surv Synth Pathol Res       Date:  1984

Review 4.  Pathogenesis of toxic shock syndrome: clinical-bacteriological correlates.

Authors:  J K Todd
Journal:  Surv Synth Pathol Res       Date:  1984

5.  Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production.

Authors:  P M Schlievert; D A Blomster; J A Kelly
Journal:  Obstet Gynecol       Date:  1984-11       Impact factor: 7.661

6.  Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits.

Authors:  J C de Azavedo; J P Arbuthnott
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus.

Authors:  M W Reeves; L Pine; J C Feeley; D E Wells
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Enhanced susceptibility of male rabbits to infection with a toxic shock strain of Staphylococcus aureus.

Authors:  G K Best; D F Scott; J M Kling; W F Crowell; J J Kirkland
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

9.  Human mononuclear leukocyte transglutaminase activity is enhanced by streptococcal erythrogenic toxin and a staphylococcal mitogenic factor associated with toxic shock syndrome.

Authors:  J G Zettergren; M J Leifer; H Nakashima; K D Wuepper
Journal:  Biochim Biophys Acta       Date:  1984-12-20

10.  Toxic shock syndrome in Oregon. Risk of recurrence.

Authors:  S D Helgerson; B L Mallery; L R Foster
Journal:  JAMA       Date:  1984-12-28       Impact factor: 56.272

View more
  23 in total

Review 1.  Superantigens: biology, immunology, and potential role in disease.

Authors:  C G Drake; B L Kotzin
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

Review 2.  Therapy of toxic shock syndrome.

Authors:  J K Todd
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

3.  Cytokine secretion induced by superantigens in peripheral blood mononuclear cells, lamina propria lymphocytes, and intraepithelial lymphocytes.

Authors:  K Sperber; L Silverstein; C Brusco; C Yoon; G E Mullin; L Mayer
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

Review 4.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice.

Authors:  Saori Nakagawa; Koji Kushiya; Ikue Taneike; Ken'ichi Imanishi; Takehiko Uchiyama; Tatsuo Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

6.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 7.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

8.  Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock.

Authors:  A G Bean; R A Freiberg; S Andrade; S Menon; A Zlotnik
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C.

Authors:  J A Mollick; G G Miller; J M Musser; R G Cook; D Grossman; R R Rich
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  MRSA infection of buttocks, vulva, and genital tract in women.

Authors:  Orna Reichman; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.